Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

Registration Brain and Central Nervous System Tumors COG ADVL0912 NCT00939770

- 24/09/15 - 1 modulo, 6 itemgroups, 61 elementi, 1 linguaggio

Itemgroups: Stratification, Inclusion Criteria, Organ Function - Hematological, Organ Function - Non Hematological, Exclusion Criteria, Consents

COG ADVL0912 OPEN Registration Worksheet NCT00939770 Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A54DD196-B288-B398-E040-BB89AD432E23

Breast Cancer NCT00377156 Registration - North Central Cancer Treatment Group Preregistration Screening Failure Form - 2467330v1.0 - North Central Cancer Treatment Group Preregistration Screening Failure Form

- 08/01/15 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio

Itemgroups: Header, Preregistration Screening Failure

North Central Cancer Treatment Group Preregistration Screening Failure Form Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=103C1A01-BDA6-395C-E044-0003BA3F9857

Breast Cancer NCT00659373 Registration - Confirmation of Registration Form (Form 24-A) - 2072688v3.0 - Confirmation of Registration Form (Form 24-A)

- 09/01/15 - 1 modulo, 4 itemgroups, 70 elementi, 1 linguaggio

Itemgroups: CCRR MODULE, Eligibility Checklist, Eligibility Checklist, STRATIFICATION FACTORS

Confirmation of Registration Form (Form 24-A) Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B0EA065B-0F5E-629F-E034-0003BA12F5E7

AMC-061 Enrollment Form (ENR) NCT00890747

- 08/07/15 - 1 modulo, 5 itemgroups, 11 elementi, 1 linguaggio

Itemgroups: Header Module, Inclusion Criteria, Exclusion Criteria, Consent For Participation in Pharmacogenetics Study and The Use Of Future Tissue Specimens, Comments

AMC-061 Enrollment Form (ENR) NCT00890747 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6DBDC738-44D1-D324-E040-BB89AD433B23

ADVL0212: Prior Therapy Worksheet NCT00053963

- 05/07/15 - 1 modulo, 6 itemgroups, 12 elementi, 1 linguaggio

Itemgroups: Header, Anti-cancer therapy, Type of Prior Therapy, Comments, General Validations, CCRR MODULE

ADVL0212: Prior Therapy Worksheet NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1EADAE4-318A-307A-E034-0003BA12F5E7

E3F05 Second Primary Form NCT00978458

- 16/06/15 - 1 modulo, 4 itemgroups, 18 elementi, 1 linguaggio

Itemgroups: ECOG clinical trial administrative data, Data amendment, Second primary cancer assessment, Footer Module

E3F05 Second Primary Form NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Neuroendocrine Carcinoma NCT00569127 Pre-Study - SOUTHWEST ONCOLOGY GROUP S0518 Prestudy Form - 2459443v1.0 - SOUTHWEST ONCOLOGY GROUP S0518 Prestudy Form

- 09/01/15 - 1 modulo, 6 itemgroups, 59 elementi, 1 linguaggio

Itemgroups: Header, Patient and Disease Description, Associated Correlative Science Consent, Laboratory Values, PRIOR TREATMENT RELATED TO THIS CANCER, Comments

SOUTHWEST ONCOLOGY GROUP S0518 Prestudy Form Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F1CE67C-C251-11F5-E044-0003BA3F9857

ANBL0321: Prior Therapy Worksheet NCT00053326

- 03/07/15 - 1 modulo, 7 itemgroups, 21 elementi, 1 linguaggio

Itemgroups: Header, Cancer Prior Treatment, Type of Prior Therapy, Stem cell transplant, Comments, General Validations/Notes, CCRR MODULE

ANBL0321: Prior Therapy Worksheet NCT00053326 Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B92CFA2B-A3FF-34F4-E034-0003BA12F5E7

Keywords

Sommario

Modelli di dati selezionati